Diag-Nose.io Projected to Enhance Global Respiratory Care Markets Following Oversubscribed $2M Seed Funding
Diag-Nose.io secures $2M to advance AI in respiratory care, aiming to optimize global disease management and treatment efficacy MELBOURNE, AUSTRALIA, January 30, 2025 /EINPresswire.com/ -- Diag-Nose.io, a trailblazer in biotechnology and a …